Alsema, AM, Jiang, Q, Kracht, L, Gerrits, E, Dubbelaar, ML, Miedema, A, and others. 2020. Profiling microglia from Alzheimer’s disease donors and non-demented elderly in acute human post-mortem cortical tissue. Front Mol Neurosci 13:134.
Google Scholar | Crossref | Medline Andreone, BJ, Przybyla, L, Llapashtica, C, Rana, A, Davis, SS, van Lengerich, B, and others. 2020. Alzheimer’s-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci 23(8):927–38.
Google Scholar | Crossref | Medline Audrain, M, Haure-Mirande, JV, Wang, MH, Kim, SH, Fanutza, T, Chakrabarty, P, and others. 2019. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry 24(9):1383–97.
Google Scholar Bemiller, SM, McCray, TJ, Allan, K, Formica, SV, Xu, G, Wilson, G, and others. 2017. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener 12(1):74.
Google Scholar | Crossref | Medline Boza-Serrano, A, Ruiz, R, Sanchez-Varo, R, Garcia-Revilla, J, Yang, Y, Jimenez-Ferrer, I, and others. 2019. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease. Acta Neuropathol 138(2):251–73.
Google Scholar | Crossref | Medline Cheng, Q, Danao, J, Talreja, S, Wen, P, Yin, J, Sun, N, and others. 2018. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer’s disease variant Trem2(R47H) on murine myeloid cell function. J Biol Chem 293(32):12620–33.
Google Scholar | Crossref Colonna, M, Wang, Y. 2016. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17(4):201–7.
Google Scholar Daws, MR, Sullam, PM, Niemi, EC, Chen, TT, Tchao, NK, Seaman, WE. 2003. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol 171(2):594–9.
Google Scholar Del-Aguila, JL, Benitez, BA, Li, Z, Dube, U, Mihindukulasuriya, KA, Budde, JP, and others. 2019. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Mol Neurodegener 14(1):18.
Google Scholar | Crossref | Medline Deussing, M, Blume, T, Zott, B, Shi, Y, Kleinberger, G, Focke, C, and others. 2019. Increasing fibrillar amyloidosis is associated with improved cognition and synaptic preservation caused by microglia modulation. J Nucl Med 60(Suppl 1):53.
Google Scholar Fassler, M, Rappaport, MS, Cuno, CB, George, J. 2021. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer’s disease models. J Neuroinflammation 18(1):19.
Google Scholar | Crossref | Medline Filipello, F, Morini, R, Corradini, I, Zerbi, V, Canzi, A, Michalski, B, and others. 2018. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 48(5):979–991.e8.
Google Scholar | Crossref | Medline Forabosco, P, Ramasamy, A, Trabzuni, D, Walker, R, Smith, C, Bras, J, and others. 2013. Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34(12):2699–714.
Google Scholar | Crossref | Medline Frigerio, CS, Wolfs, L, Fattorelli, N, Thrupp, N, Voytyuk, I, Schmidt, I, and others. 2019. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep 27(4):1293–1306.e6.
Google Scholar Gabande-Rodriguez, E, Keane, L, Capasso, M. 2020. Microglial phagocytosis in aging and Alzheimer’s disease. J Neurosci Res 98(2):284–98.
Google Scholar | Crossref | Medline Gefen, T, Kim, G, Bolbolan, K, Geoly, A, Ohm, D, Oboudiyat, C, and others. 2019. Activated microglia in cortical white matter across cognitive aging trajectories. Front Aging Neurosci 11:94.
Google Scholar | Crossref | Medline Gratuze, M, Leyns, CE, Sauerbeck, AD, St-Pierre, M-K, Xiong, M, Kim, N, and others. 2020. Impact of TREM2 R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest 130(9):4954–68.
Google Scholar | Crossref | Medline Gratuze, M, Leyns, CEG, Holtzman, DM. 2018. New insights into the role of TREM2 in Alzheimer’s disease. Mol Neurodegener 13(1):66.
Google Scholar | Crossref | Medline Griciuc, A, Patel, S, Federico, AN, Choi, SH, Innes, BJ, Oram, MK, and others. 2019. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer’s disease. Neuron 103(5):820–835.e7.
Google Scholar | Crossref | Medline Guerreiro, R, Wojtas, A, Bras, J, Carrasquillo, M, Rogaeva, E, Majounie, E, and others. 2013. TREM2 variants in Alzheimer’s disease. N Engl J Med 368(2):117–27.
Google Scholar | Crossref | Medline Hall-Roberts, H, Agarwal, D, Obst, J, Smith, TB, Monzon-Sandoval, J, Di Daniel, E, and others. 2020. TREM2 Alzheimer’s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages. Alzheimers Res Ther 12(1):151.
Google Scholar | Crossref | Medline Haure-Mirande, JV, Audrain, M, Fanutza, T, Kim, SH, Klein, WL, Glabe, C, and others. 2017. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. Acta Neuropathol 134(5):769–88.
Google Scholar | Crossref | Medline He, Z, Guo, JL, McBride, JD, Narasimhan, S, Kim, H, Changolkar, L, and others. 2018. Amyloid-beta plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24(1):29–38.
Google Scholar | Crossref | Medline Jadhav, VS, Lin, PBC, Pennington, T, Di Prisco, GV, Jannu, AJ, Xu, G, and others. 2020. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice. Mol Neurodegener 15(1):62.
Google Scholar | Crossref | Medline Jay, TR, Hirsch, AM, Broihier, ML, Miller, CM, Neilson, LE, Ransohoff, RM, and others. 2017a. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer’s disease. J Neurosci 37(3):637–47.
Google Scholar | Crossref | Medline Jay, TR, Miller, CM, Cheng, PJ, Graham, LC, Bemiller, S, Broihier, ML, and others. 2015. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models. J Exp Med 212(3):287–95.
Google Scholar | Crossref Jay, TR, von Saucken, VE, Landreth, GE. 2017b. TREM2 in neurodegenerative diseases. Mol Neurodegener 12(1):56.
Google Scholar | Crossref | Medline Jay, TR, von Saucken, VE, Munoz, B, Codocedo, JF, Atwood, BK, Lamb, BT, and others. 2019. TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment. Glia 67(10):1873–92.
Google Scholar | Medline Jonsson, T, Stefansson, H, Steinberg, S, Jonsdottir, I, Jonsson, PV, Snaedal, J, and others. 2013. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368(2):107–16.
Google Scholar | Crossref | Medline Kaneko, M, Sano, K, Nakayama, J, Amano, N. 2010. Nasu-Hakola disease: the first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology. Neuropathology 30(5):463–70.
Google Scholar | Medline Kang, SS, Kurti, A, Baker, KE, Liu, CC, Colonna, M, Ulrich, JD, and others. 2018. Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal. Hum Mol Genet 27(2):211–23.
Google Scholar Keren-Shaul, H, Spinrad, A, Weiner, A, Matcovitch-Natan, O, Dvir-Szternfeld, R, Ulland, TK, and others. 2017. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169(7):1276–1290.e17.
Google Scholar | Crossref | Medline Kim, SM, Mun, BR, Lee, SJ, Joh, Y, Lee, HY, Ji, KY, and others. 2017. TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia. Sci Rep 7(1):11118.
Google Scholar | Crossref | Medline Kober, DL, Brett, TJ. 2017. TREM2-ligand interactions in health and disease. J Mol Biol 429(11):1607–29.
Google Scholar | Crossref | Medline Konishi, H, Kiyama, H. 2018. Microglial TREM2/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci 12:206.
Google Scholar Korvatska, O, Leverenz, JB, Jayadev, S, McMillan, P, Kurtz, I, Guo, X, and others. 2015. R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study. JAMA Neurol 72(8):920–7.
Google Scholar Krasemann, S, Madore, C, Cialic, R, Baufeld, C, Calcagno, N, El Fatimy, R, and others. 2017. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566–581.e9.
Google Scholar | Crossref | Medline Larson, J, Munkácsy, E. 2015. Theta-burst LTP. Brain Res 1621:38–50.
Google Scholar | Crossref | Medline Lee, SH, Meilandt, WJ, Xie, L, Gandham, VD, Ngu, H, Barck, KH, and others. 2021. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology. Neuron 109(8):1283–1301.e6.
Google Scholar | Crossref Leyns, CEG, Gratuze, M, Narasimhan, S, Jain, N, Koscal, LJ, Jiang, H, and others. 2019. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci 22(8):1217–22.
Google Scholar | Crossref | Medline Leyns, CEG, Ulrich, JD, Finn, MB, Stewart, FR, Koscal, LJ, Remolina Serrano, J, and others. 2017. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A 114(43):11524–9.
Google Scholar | Crossref | Medline Lill, CM, Rengmark, A, Pihlstrom, L, Fogh, I, Shatunov, A, Sleiman, PM, and others. 2015. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement 11(12):1407–16.
Google Scholar | Crossref | Medline Linnartz-Gerlach, B, Bodea, LG, Klaus, C, Ginolhac, A, Halder, R, Sinkkonen, L, and others. 2019. TREM2 triggers microglial density and age-related neuronal loss. Glia 67(3):539–50.
Google Scholar | Crossref | Medline Lue, LF, Schmitz, CT, Serrano, G, Sue, LI, Beach, TG, Walker, DG. 2015. TREM 2 protein expression changes correlate with Alzheimer’s disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol 25(4):469–80.
Google Scholar | Crossref | Medline Maes, ME, Colombo, G, Schulz, R, Siegert, S. 2019. Targeting microglia with lentivirus and AAV: recent advances and remaining challenges. Neurosci Lett 707:134310.
Google Scholar McQuade, A, Kang, YJ, Hasselmann, J, Jairaman, A, Sotelo, A, Coburn, M, and others. 2020. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease. Nat Commun 11(1):5370.
Google Scholar | Crossref | Medline Meilandt, WJ, Ngu, H, Gogineni, A, Lalehzadeh, G, Lee, SH, Srinivasan, K, and others. 2020. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Aβ42:Aβ40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer’s mouse model. J Neurosci 40(9):1956–74.
Google Scholar | Crossref | Medline Nugent, AA, Lin, K, van Lengerich, B, Lianoglou, S, Przybyla, L, Davis, SS, and others. 2020. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron 105(5):837–854.e9.
Google Scholar | Crossref | Medline Olah, M, Menon, V, Habib, N, Taga, MF, Ma, Y, Yung, CJ, and others. 2020. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. Nat Commun 11(1):6129.
Google Scholar | Crossref | Medline Otero, K, Turnbull, IR, Poliani, PL, Vermi, W, Cerutti, E, Aoshi, T, and others. 2009. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin. Nat Immunol 10(7):734–43.
Google Scholar | Crossref | Medline Painter, MM, Atagi, Y, Liu, CC, Rademakers, R, Xu, H, Fryer, JD, and others. 2015. TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener 10(1):43.
Google Scholar | Crossref | Medline Parhizkar, S, Arzberger, T, Brendel, M, Kleinberger, G, Deussing, M, Focke, C, and others. 2019. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22(2):191–204.
Google Scholar | Crossref | Medline